Annual Operating Expenses
$110.98 M
-$29.40 M-20.94%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual total operating expenses is currently $110.98 million, with the most recent change of -$29.40 million (-20.94%) on 31 December 2023. During the last 3 years, it has fallen by -$1.78 million (-1.58%). LGND annual operating expenses is now -20.94% below its all-time high of $140.38 million, reached on 31 December 2022.LGND Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$38.41 M
+$7.17 M+22.97%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly total operating expenses is currently $38.41 million, with the most recent change of +$7.17 million (+22.97%) on 30 September 2024. Over the past year, it has increased by +$9.98 million (+35.12%). LGND quarterly operating expenses is now -44.30% below its all-time high of $68.95 million, reached on 31 March 2004.LGND Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.9% | +35.1% |
| 3 y3 years | -1.6% | +1.9% |
| 5 y5 years | +36.4% | +43.2% |
LGND Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -20.9% | +47.0% | -21.4% | +400.3% |
| 5 y | 5 years | -20.9% | +47.0% | -21.4% | +400.3% |
| alltime | all time | -20.9% | +1068.2% | -44.3% | +208.1% |
Ligand Pharmaceuticals Incorporated Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $38.41 M(+23.0%) |
| June 2024 | - | $31.23 M(+24.4%) |
| Mar 2024 | - | $25.11 M(-15.8%) |
| Dec 2023 | $110.98 M(-20.9%) | $29.82 M(+4.9%) |
| Sept 2023 | - | $28.43 M(+6.5%) |
| June 2023 | - | $26.68 M(+2.4%) |
| Mar 2023 | - | $26.06 M(-46.7%) |
| Dec 2022 | $140.38 M(+85.9%) | $48.87 M(+49.3%) |
| Sept 2022 | - | $32.73 M(+12.5%) |
| June 2022 | - | $29.10 M(-2.0%) |
| Mar 2022 | - | $29.68 M(-332.1%) |
| Dec 2021 | $75.52 M(-33.0%) | -$12.79 M(-133.9%) |
| Sept 2021 | - | $37.68 M(+351.7%) |
| June 2021 | - | $8.34 M(-80.3%) |
| Mar 2021 | - | $42.28 M(+42.6%) |
| Dec 2020 | $112.76 M(-1.7%) | $29.64 M(-6.6%) |
| Sept 2020 | - | $31.75 M(+19.0%) |
| June 2020 | - | $26.68 M(+8.0%) |
| Mar 2020 | - | $24.69 M(-29.9%) |
| Dec 2019 | $114.66 M(+40.9%) | $35.24 M(+31.4%) |
| Sept 2019 | - | $26.82 M(+0.4%) |
| June 2019 | - | $26.71 M(+3.2%) |
| Mar 2019 | - | $25.88 M(+10.2%) |
| Dec 2018 | $81.39 M(+20.3%) | $23.49 M(+12.7%) |
| Sept 2018 | - | $20.84 M(+11.2%) |
| June 2018 | - | $18.73 M(+2.2%) |
| Mar 2018 | - | $18.33 M(-10.1%) |
| Dec 2017 | $67.66 M(+13.7%) | $20.38 M(+40.6%) |
| Sept 2017 | - | $14.50 M(+3.0%) |
| June 2017 | - | $14.08 M(-24.8%) |
| Mar 2017 | - | $18.71 M(+17.4%) |
| Dec 2016 | $59.52 M(+53.5%) | $15.93 M(+5.1%) |
| Sept 2016 | - | $15.15 M(+2.2%) |
| June 2016 | - | $14.83 M(+9.1%) |
| Mar 2016 | - | $13.60 M(+34.9%) |
| Dec 2015 | $38.78 M(+11.8%) | $10.08 M(+34.2%) |
| Sept 2015 | - | $7.51 M(-33.2%) |
| June 2015 | - | $11.23 M(+12.8%) |
| Mar 2015 | - | $9.96 M(+13.2%) |
| Dec 2014 | $34.69 M(+27.3%) | $8.80 M(-9.9%) |
| Sept 2014 | - | $9.76 M(+23.1%) |
| June 2014 | - | $7.93 M(-3.4%) |
| Mar 2014 | - | $8.20 M(+20.7%) |
| Dec 2013 | $27.26 M(+2.6%) | $6.79 M(-5.2%) |
| Sept 2013 | - | $7.17 M(+13.3%) |
| June 2013 | - | $6.33 M(-9.2%) |
| Mar 2013 | - | $6.97 M(+4.3%) |
| Dec 2012 | $26.57 M(+6.8%) | $6.68 M(-4.0%) |
| Sept 2012 | - | $6.95 M(+3.7%) |
| June 2012 | - | $6.71 M(+7.6%) |
| Mar 2012 | - | $6.23 M(+5.3%) |
| Dec 2011 | $24.87 M(-28.7%) | $5.92 M(-8.0%) |
| Sept 2011 | - | $6.43 M(-9.3%) |
| June 2011 | - | $7.09 M(+30.6%) |
| Mar 2011 | - | $5.43 M(-158.3%) |
| Dec 2010 | $34.90 M(-50.4%) | -$9.32 M(-139.0%) |
| Sept 2010 | - | $23.90 M(+141.6%) |
| June 2010 | - | $9.89 M(-5.0%) |
| Mar 2010 | - | $10.41 M(-69.9%) |
| Dec 2009 | $70.32 M | $34.57 M(+385.1%) |
| Sept 2009 | - | $7.13 M(-39.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $11.81 M(-31.7%) |
| Mar 2009 | - | $17.28 M(+9.8%) |
| Dec 2008 | $54.55 M(-27.3%) | $15.74 M(+35.7%) |
| Sept 2008 | - | $11.60 M(+11.2%) |
| June 2008 | - | $10.44 M(-39.5%) |
| Mar 2008 | - | $17.26 M(+9.4%) |
| Dec 2007 | $75.03 M(-8.6%) | $15.78 M(+11.1%) |
| Sept 2007 | - | $14.20 M(-10.0%) |
| June 2007 | - | $15.78 M(-46.1%) |
| Mar 2007 | - | $29.28 M(+25.9%) |
| Dec 2006 | $82.06 M(+52.4%) | $23.26 M(+3.6%) |
| Sept 2006 | - | $22.45 M(+17.4%) |
| June 2006 | - | $19.12 M(+11.0%) |
| Mar 2006 | - | $17.23 M(-148.5%) |
| Dec 2005 | $53.84 M(-50.7%) | -$35.55 M(-217.8%) |
| Sept 2005 | - | $30.17 M(-27.5%) |
| June 2005 | - | $41.64 M(-0.1%) |
| Mar 2005 | - | $41.69 M(-398.5%) |
| Dec 2004 | $109.23 M(-15.0%) | -$13.97 M(-137.0%) |
| Sept 2004 | - | $37.72 M(-9.5%) |
| June 2004 | - | $41.68 M(-39.6%) |
| Mar 2004 | - | $68.95 M(+80.7%) |
| Dec 2003 | $128.58 M(+27.5%) | $38.17 M(+23.5%) |
| Sept 2003 | - | $30.91 M(+1.6%) |
| June 2003 | - | $30.43 M(+4.7%) |
| Mar 2003 | - | $29.07 M(+4.8%) |
| Dec 2002 | $100.89 M(+18.0%) | $27.75 M(+5.1%) |
| Sept 2002 | - | $26.41 M(+10.2%) |
| June 2002 | - | $23.96 M(+5.2%) |
| Mar 2002 | - | $22.77 M(+9.5%) |
| Dec 2001 | $85.53 M(+0.2%) | $20.80 M(+3.6%) |
| Sept 2001 | - | $20.09 M(-12.7%) |
| June 2001 | - | $23.01 M(-2.1%) |
| Mar 2001 | - | $23.50 M(+12.0%) |
| Dec 2000 | $85.40 M(-6.9%) | $20.98 M(-3.7%) |
| Sept 2000 | - | $21.79 M(-17.4%) |
| June 2000 | - | $26.36 M(+23.3%) |
| Mar 2000 | - | $21.39 M(+32.0%) |
| Dec 1999 | $91.70 M(-0.1%) | $16.20 M(-37.2%) |
| Sept 1999 | - | $25.80 M(-1.5%) |
| June 1999 | - | $26.20 M(+11.5%) |
| Mar 1999 | - | $23.50 M(-13.9%) |
| Dec 1998 | $91.80 M(-0.5%) | $27.30 M(+20.8%) |
| Sept 1998 | - | $22.60 M(+0.9%) |
| June 1998 | - | $22.40 M(+14.9%) |
| Mar 1998 | - | $19.50 M(-26.1%) |
| Dec 1997 | $92.30 M(+16.7%) | $26.40 M(+14.8%) |
| Sept 1997 | - | $23.00 M(+6.5%) |
| June 1997 | - | $21.60 M(+1.9%) |
| Mar 1997 | - | $21.20 M(-6.6%) |
| Dec 1996 | $79.10 M(+49.0%) | $22.70 M(+4.6%) |
| Sept 1996 | - | $21.70 M(+16.7%) |
| June 1996 | - | $18.60 M(+16.3%) |
| Mar 1996 | - | $16.00 M(-3.0%) |
| Dec 1995 | $53.10 M(+458.9%) | $16.50 M(+8.6%) |
| Sept 1995 | - | $15.20 M(+61.7%) |
| Mar 1995 | - | $9.40 M(+176.5%) |
| Dec 1994 | $9.50 M | $3.40 M(+61.9%) |
| Sept 1994 | - | $2.10 M(+5.0%) |
| June 1994 | - | $2.00 M(0.0%) |
| Mar 1994 | - | $2.00 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual total operating expenses?
- What is the all time high annual operating expenses for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual operating expenses year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly operating expenses year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual total operating expenses?
The current annual operating expenses of LGND is $110.98 M
What is the all time high annual operating expenses for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual total operating expenses is $140.38 M
What is Ligand Pharmaceuticals Incorporated annual operating expenses year-on-year change?
Over the past year, LGND annual total operating expenses has changed by -$29.40 M (-20.94%)
What is Ligand Pharmaceuticals Incorporated quarterly total operating expenses?
The current quarterly operating expenses of LGND is $38.41 M
What is the all time high quarterly operating expenses for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly total operating expenses is $68.95 M
What is Ligand Pharmaceuticals Incorporated quarterly operating expenses year-on-year change?
Over the past year, LGND quarterly total operating expenses has changed by +$9.98 M (+35.12%)